文献速递免疫规划卫生政策与健康促进

减毒活流感疫苗后晕厥:疫苗不良事件报告系统报告(2003-2024年)

Syncope after live attenuated influenza vaccine: Reports to the Vaccine Adverse Event Reporting System (2003-2024).
PubMed 文献 · Vaccine · 2024-09-06

基于美国疫苗不良事件报告系统(VAERS),回顾2003年6月17日至2024年5月31日单独接种鼻内减毒活流感疫苗(LAIV)后晕厥的报告,共50例,近半为10-19岁人群,30%受伤,74%在接种后15分钟内发生晕厥,报告率约0.4/百万剂,提示LAIV后晕厥罕见。

要点

  • 50例LAIV后晕厥报告中,23例(46%)为10-19岁人群。
  • 15例(30%)因晕厥受伤,最常见为跌倒致头部或面部受伤。
  • 37例(74%)在接种后15分钟内发生晕厥,但仅24例(48%)报告在观察区等待至少15分钟。

核心结论

  • 本文汇总的信息可能有助于临床医生、患者和照护者在预防LAIV相关晕厥后可能发生的伤害方面做出更知情的决定。

研究设计与样本

  • 利用疫苗不良事件报告系统(VAERS)回顾并总结2003年6月17日至2024年5月31日单独接种鼻内减毒活流感疫苗(LAIV)后晕厥的报告,共50例。

主要发现

  • 50例报告中,23例(46%)涉及10-19岁个体。
  • 35例(70%)未描述任何伤害,15例(30%)受伤,最常见为跌倒致头部或面部受伤。
  • 22例(44%)需要在急诊科或医生办公室评估,包括1例在驾车回家途中失去意识者,未报告伤害但车辆严重损坏。
  • 37例(74%)在接种后15分钟内发生晕厥,但仅24例(48%)报告患者在观察区等待至少15分钟。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vasovagal syncope, or fainting, can be triggered by various stimuli, including medical procedures. Syncope after vaccination has been reported, most commonly among adolescents, and can result in injuries. Using the Vaccine Adverse Event Reporting System (VAERS), we reviewed and summarized reports of syncope after live attenuated influenza vaccine, intranasal (LAIV) administered as the sole vaccine (i.e., no concomitant injections). From June 17, 2003 (date of LAIV licensure in the US) through May 31, 2024, VAERS received 50 reports of syncope after LAIV. Nearly half (23; 46 %) pertained to individuals 10-19 years of age. While the vast majority of reports (35; 70 %) did not describe any injuries, 15 people (30 %) were injured, most commonly by falling and hitting their head or face. Twenty-two people (44 %) required evaluation in the emergency department or doctor's office, including an individual who lost consciousness while he was driving home from the vaccination appointment. He did not report any injuries, but the car was severely damaged. Nearly three-quarters of people (37; 74 %) developed syncope within 15 min after vaccination, but fewer than half of reports (24; 48 %) stated that the patient had waited in the observation area for at 15 min. Based on approximately 111.9 million doses of LAIV distributed in the US during the same time period, the reporting rate is approximately 0.4 per million doses, suggesting that syncope following LAIV is rare. The information summarized here may enable clinicians, patients, and caregivers to make a more informed decision regarding preventing injuries that may occur following LAIV-related syncope.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Woo EJ, Miller ER, Stroud E, et al. Syncope after live attenuated influenza vaccine: Reports to the Vaccine Adverse Event Reporting System (2003-2024). Vaccine. 2024. PMID: 39241357. doi:10.1016/j.vaccine.2024.126290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。